Inotuzumab ozogamicin in the treatment of B-cell acute lymphoblastic leukemia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.6, 2012-06, pp. : 871-878

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Lymphoblastic Leukemia: Optimizing Treatment Strategies in Children

By Vora A.

Pediatric Drugs, Vol. 4, Iss. 6, 2002-01 ,pp. : 405-416

Adis International

Access to resources Recommend Favorite

Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer

By Taghdisi Seyed Mohammad Abnous Khalil Mosaffa Fatemeh Behravan Javad

Journal of Drug Targeting, Vol. 18, Iss. 4, 2010-05 ,pp. : 277-281

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia

Current Pharmacogenomics, Vol. 1, Iss. 2, 2003-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Treatments in Acute Lymphoblastic Leukemia

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 19-31

Bentham Science Publishers

Access to resources Recommend Favorite

Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B‐cell precursor acute lymphoblastic leukaemia

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 245-251

John Wiley & Sons Inc

Access to resources Recommend Favorite